Advanced Endoscopy During COVID-19

Al-Azhar University670 enrolled

Overview

In this study, investigators aim to explore the status of advanced endoscopy in different endoscopy units all over the world.

In this study, investigators aim to explore the status of advanced endoscopy (endoscopic retrograde cholangiopancreatography and endoscopic ultrasound on a global level) in different endoscopy units all over the world, to report the characteristics of patients presented to these units and their procedure details. evaluate the validity of different GI societies recommendations applied in different GI endoscopy units on the prevention of SARS-CoV-2 nosocomial transmission and the overall impact of this recommendations on the service provided by each GI unit. Target audience: \- Physicians performing advanced gastrointestinal endoscopies in different countries. Objectives: * Primary objective: 1- To explore the status of advanced endoscopy (endoscopic retrograde cholangiopancreatography and endoscopic ultrasound on a global level) in different endoscopy units all over the world, to report the characteristics of patients presented to these units and their procedure details. * Secondary objectives: 1. Effect of COVID-19 precautions on procedure time, procedure success, complications and patient outcomes 2. Effect of COVID-19 on working time and staff number Process: A questionnaire containing advanced endoscopy procedure details in different countries will be distributed via emails. Responses will be collected in an online platform and data will be analyzed to reveal the effect of SARS-CoV-2 pandemic on different aspects of advanced endoscopy practice in the studied countries.

Study Type

OBSERVATIONAL

Enrollment

670

Conditions

Cholangitis, Secondary Biliary Cholangiocarcinoma Obstructive Jaundice Pancreas Cancer COVID-19 SARS-CoV-2

Interventions

Endoscopic management according to standard of careOTHER

Endoscopic management according to standard of care by ERCP or EUS according to the indication in each case

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patients referred for ERCP or EUS during the study period Exclusion Criteria: * Patients refusing to participate in the study

Locations (5)

Kings County Hospital Center, Brooklyn, NY, USA

Albertson, New York, United States

Al-Azhar Univerisity

Cairo, Egypt

University Medicine Greifswald

Greifswald, Germany

2- Hospital Guillermo Kaelin De la Fuente - EsSalud

Lima, Peru

Outcomes

Primary Outcomes

Age, gender, nationality

Investigators will report the baseline demographic data (age, gender, nationality) of all patients.

Time frame: 3 months

Indication for procedure, status of SARS-CoV-2 infection

Investigators will report the baseline data clinical data (indication for procedure, status of SARS-CoV-2 infection) of all patients.

Time frame: 3 months

Complete blood count and liver functions tests

Investigators will report the baseline laboratory data (complete blood count and liver functions tests) of all patients.

Time frame: 3 months

procedure related complications

Investigators will report the procedure related complications.

Time frame: 3 months

Secondary Outcomes

Effect of COVID-19 precautions on procedure time

Investigators will report wether the precautions lead to increase timing of the procedure

Time frame: 3 months

Effect of COVID-19 precautions on staff number

Investigators will report wether the precautions affected staff number (increased or decreased)

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.